Australia's Therapeutic Goods Administration (TGA) has recognized the two-dose course of the Russian Sputnik V vaccine against COVID-19 as an acceptable form of coronavirus vaccination for travellers.
"Today, the TGA determined that an additional COVID-19 vaccine, the two-dose course of the Gamaleya Institute vaccine (Sputnik V, Russian Federation) would be 'recognized' for the purpose of establishing a traveller's vaccination status," the TGA said in a Monday statement.
The regulator explained that additional data on the Russian vaccine's effectiveness showed that two doses of Sputnik V demonstrated an average efficacy against symptomatic COVID-19 infection of 89 percent and against hospitalization or death of 98-100 percent.
"The single-dose course of the Gamaleya vaccine ('Sputnik Light') is not currently recognized by the TGA," the Australian regulator specified.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU